Clinical Diagnosis and Phar-maceutical Management of Inflammatory Bowel Disease

炎症性肠病 医学 疾病 指南 溃疡性结肠炎 重症监护医学 克罗恩病 结肠炎 疾病管理 医疗保健 内科学 病理 经济增长 经济 帕金森病
作者
Amosy E. M’Koma
出处
期刊:Medical research archives [Knowledge Enterprises Journals]
卷期号:11 (1) 被引量:3
标识
DOI:10.18103/mra.v11i1.3135
摘要

Inflammatory bowel disease has an enormous impact on public health, medical systems, economies, and social conditions. Biologic therapy has ameliorated the treatment and clinical course of patients with inflammatory bowel disease. The efficacy and safety profiles of currently available therapies are still less that optimal in numerous ways, highlighting the requirement for new therapeutic targets. A bunch of new drug studies are underway in inflammatory bowel disease with promising results. This is an outlined guideline of clinical diagnosis and pharmaceutical therapy of inflammatory bowel disease. Outline delineates the overall recommendations on the modern principles of desirable practice to bolster the adoption of best implementations and exploration as well as inflammatory bowel disease patient, gastroenterologist, and other healthcare provider education. Inflammatory bowel disease encompasses Crohn's disease and ulcerative colitis, the two unsolved medical inflammatory bowel disease-subtypes condition with no drug for cure. The signs and symptoms on first presentation relate to the anatomical localization and severity of the disease and less with the resulting diagnosis that can clinically and histologically be non-definitive to interpret and establish criteria, specifically in colonic inflammatory bowel disease when the establishment is inconclusive is classified as indeterminate colitis. Conservative pharmaceuticals and accessible avenues do not depend on the disease phenotype. The first line management is to manage symptoms and stabilize active disease; at the same time maintenance therapy is indicated. Nutrition and diet do not play a primary therapeutic role but is warranted as supportive care. There is need of special guideline that explore solution of groundwork gap in terms of access limitations to inflammatory bowel disease care, particularly in developing countries and the irregular representation of socioeconomic stratification with a strategic plan, for the unanswered questions and perspective for the future, especially during the surfaced global COVID-19 pandemic caused by coronavirus SARS-CoV2 impacting on both the patient's psychological functioning and endoscopy services. Establishment of a global registry system and accumulated experiences have led to consensus for inflammatory bowel disease management under the COVID-19 pandemic. Painstakingly, the pandemic has influenced medical care systems for these patients. I briefly herein viewpoint summarize among other updates the telemedicine roles during the pandemic and how operationally inflammatory bowel disease centers managed patients and ensured quality of care. In conclusion: inflammatory bowel disease has become a global emergent disease. Serious medical errors are public health problem observed in developing nations i.e., to distinguish inflammatory bowel disease and infectious and parasitic diseases. Refractory inflammatory bowel disease is a still significant challenge in the management of patients with Crohn's disease and ulcerative colitis. There are gaps in knowledge and future research directions on the recent newly registered pharmaceuticals. The main clinical outcomes for inflammatory bowel disease were maintained during the COVID-19 pandemic period.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
QS完成签到,获得积分10
刚刚
刚刚
爆米花应助夕荀采纳,获得10
1秒前
1秒前
暖若安阳发布了新的文献求助10
2秒前
Yxy发布了新的文献求助10
2秒前
忧伤的碧凡完成签到,获得积分10
3秒前
Yjh完成签到,获得积分10
3秒前
3秒前
大气乐儿完成签到,获得积分10
3秒前
3秒前
3秒前
3秒前
3秒前
4秒前
张张发布了新的文献求助10
4秒前
4秒前
xzw发布了新的文献求助20
4秒前
慕青应助zz采纳,获得10
4秒前
水沐菁华完成签到,获得积分10
6秒前
6秒前
tyhmugua发布了新的文献求助10
6秒前
阳光的山雁完成签到,获得积分10
6秒前
风趣的梦露完成签到 ,获得积分10
6秒前
哦哦发布了新的文献求助10
6秒前
肖肖完成签到,获得积分10
7秒前
Aurora完成签到 ,获得积分10
8秒前
科研通AI5应助甘甘采纳,获得10
8秒前
阿豪完成签到,获得积分10
8秒前
8秒前
科研通AI5应助byy采纳,获得10
8秒前
Max发布了新的文献求助10
8秒前
二尖瓣后叶完成签到,获得积分10
9秒前
9秒前
。。。发布了新的文献求助30
9秒前
李健应助暖若安阳采纳,获得10
9秒前
9秒前
10秒前
聆听雨完成签到,获得积分10
10秒前
10秒前
高分求助中
Continuum thermodynamics and material modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation 2000
Population Genetics 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Les Mantodea de Guyane Insecta, Polyneoptera 1000
Theory of Block Polymer Self-Assembly 750
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3492094
求助须知:如何正确求助?哪些是违规求助? 3078484
关于积分的说明 9154856
捐赠科研通 2771008
什么是DOI,文献DOI怎么找? 1520770
邀请新用户注册赠送积分活动 704758
科研通“疑难数据库(出版商)”最低求助积分说明 702473